TipRanks
Definium Therapeutics (DFTX)
NASDAQ:DFTX
US Market
DFTX
Definium Therapeutics
RESEARCH TOOLSreports
Want to see DFTX full AI Analyst Report?

Definium Therapeutics (DFTX) Stock News & Sentiment

2,471 Followers
Definium Therapeutics Set to Reveal Phase 3 Panorama Results for DT120 in Generalized Anxiety Disorder
Premium
Company Announcements
Definium Therapeutics Set to Reveal Phase 3 Panorama Results for DT120 in Generalized Anxiety Disorder
7d ago
DFTX
Definium Therapeutics Issues Inducement Stock Options to New Hires
Premium
Company Announcements
Definium Therapeutics Issues Inducement Stock Options to New Hires
7d ago
DFTX
Definium Therapeutics Logs Third Positive Phase 3 Readout for DT120 in Anxiety
Premium
Company Announcements
Definium Therapeutics Logs Third Positive Phase 3 Readout for DT120 in Anxiety
7d ago
DFTX
Definium Therapeutics Issues Inducement Stock Options to New Hires
Premium
Company Announcements
Definium Therapeutics Issues Inducement Stock Options to New Hires
7d ago
DFTX
Definium Wins Second FDA Breakthrough Tag for Psychedelic MDD Drug
Premium
Company Announcements
Definium Wins Second FDA Breakthrough Tag for Psychedelic MDD Drug
7d ago
DFTX
Definium to Unveil Phase 3 DT120 Data in Anxiety and Depression at Psych Congress 2026
Premium
Company Announcements
Definium to Unveil Phase 3 DT120 Data in Anxiety and Depression at Psych Congress 2026
7d ago
DFTX
Definium reports positive Phase 3 results for DT120
Premium
Company Announcements
Definium reports positive Phase 3 results for DT120
10d ago
8K
DFTX
More DFTX News >

DFTX News on the Web

Definium Therapeutics Inc at TD Cowen Novel Mechanisms in Neuropsychiatry Conference (Virtual) ...
GuruFocus News
Neutral
Definium’s LSD Pill Clears a Second Anxiety Trial, and the Psychedelics Sector Is Watching
Insider Monkey
Bullish
Analysts Offer Insights on Healthcare Companies: Contineum Therapeutics, Inc. Class A (CTNM) and Definium Therapeutics (DFTX)
TipRanks News
Bullish
Definium Therapeutics Set to Reveal Phase 3 Panorama Results for DT120 in Generalized Anxiety Disorder
TipRanks News
Neutral
Definium Therapeutics Logs Third Positive Phase 3 Readout for DT120 in Anxiety
TipRanks News
Neutral
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Definium Therapeutics (DFTX) and enGene Holdings (ENGN)
TipRanks News
Bullish
Stifel Nicolaus Reaffirms Their Buy Rating on Definium Therapeutics (DFTX)
TipRanks News
Bullish
Definium Therapeutics price target raised to $75 from $70 at Oppenheimer
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
DFTX
Sector Average
Media Buzz
This Week4 articles
Weekly Average10 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DFTX’s Media Buzz Sentiment?
4 articles about DFTX were published this week. In an average week, 10 articles are published.
    What is DFTX’s weekly average amount of articles?
    In an average week, 10 articles about DFTX are published.
      What is DFTX’s News Sentiment?
      100% of articles about DFTX were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        MRNAModerna
        ABEOAbeona Therapeutics
        ANABAnaptysBio
        VKTXViking Therapeutics
        AXSMAxsome Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week